Dana Farber/Harvard Cancer Center - PO box 849168

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Relapsed/Refractory Aggressive B-Cell Lymphoma

Studies at this site

• A Study to Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients With B-cell Malignancies — Completed